Aristo Bio-Tech Stock Price Analysis and Quick Research Report. Is Aristo Bio-Tech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aristo Bio-Tech. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aristo Bio-Tech has a PE ratio of 9.76331080504659 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aristo Bio-Tech has ROA of 3.0332% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aristo Bio-Tech has a Current ratio of 1.2112.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aristo Bio-Tech has a ROE of 11.455%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Aristo Bio-Tech has a Debt to Equity ratio of 0.5854 which means that the company has low proportion of debt in its capital.

• Sales growth: Aristo Bio-Tech has reported revenue growth of 29.7554% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Aristo Bio-Tech for the current financial year is 2.91531368057173%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aristo Bio-Tech is Rs 0.5 and the yield is 0.5825%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aristo Bio-Tech is Rs 10.5497. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aristo Bio-Tech in Ticker for free. Also, one can get the intrinsic value of Aristo Bio-Tech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Aristo Bio-Tech FAQs

Q1. What is Aristo Bio-Tech share price today?
Ans: The current share price of Aristo Bio-Tech is Rs 103.

Q2. What is the market capitalisation of Aristo Bio-Tech?
Ans: Aristo Bio-Tech has a market capitalisation of Rs 70.12034 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Aristo Bio-Tech?
Ans: The PE ratio of Aristo Bio-Tech is 9.76331080504659 and the P/B ratio of Aristo Bio-Tech is 1.87832468027449, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Aristo Bio-Tech share?
Ans: The 52-week high share price of Aristo Bio-Tech is Rs 140, and the 52-week low share price of Aristo Bio-Tech is Rs 74.3.

Q5. Does Aristo Bio-Tech pay dividends?
Ans: Currently, Aristo Bio-Tech pays dividends. Dividend yield of Aristo Bio-Tech is around 0.5825%.

Q6. What are the face value and book value of Aristo Bio-Tech shares?
Ans: The face value of Aristo Bio-Tech shares is Rs 10, while the book value per share of Aristo Bio-Tech is around Rs 54.8361. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Aristo Bio-Tech?
Ans: Aristo Bio-Tech has a total debt of Rs 21.8543 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Aristo Bio-Tech?
Ans: The ROE of Aristo Bio-Tech is 11.455% and ROCE of Aristo Bio-Tech is 12.9577%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Aristo Bio-Tech a good buy for the long term?
Ans: The Aristo Bio-Tech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Aristo Bio-Tech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Aristo Bio-Tech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Aristo Bio-Tech’s financials?
Ans: You can review Aristo Bio-Tech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.